Drug details

Lupkynis (voclosporin capsules)

type of Calcineurin Inhibitors

Lupkynis (voclosporin) is a calcineurin-inhibitor immunosuppressant indicated in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis (LN).

The drug is often used to treat Lupus .

This drug may have the following side effects:

• swelling of your face, lips, tongue, or throat,
• shortness of breath,
• chest pain,
• nausea,
• headache,
• numbness,
• blurred vision,
• weakness,
• pale skin,
• tiredness,
• lightheadedness, and
• hives, 
• difficulty breathing, 
• confusion, 
• seizures, 
• cold hands and feet
• pain or burning when you urinate, 
• tremors, 
• vision changes, 
• tingling,
• unusual tiredness, 
• severe headache, 
• pounding in your neck or ears, 
• little or no urination, 
• irregular heartbeats, 
• tingly feeling,
• swelling in your feet or ankles, 
• feeling less alert, 
• loss of movement, 

The following drugs are related to Lupkynis, either as a replacement or used together:

• Imuran (azathioprine)
• Benlysta (belimumab)
• CellCept (mycophenolate mofetil)
• Cytoxan (cyclophosphamide)
• Sandimmune (cyclosporine)
• Prednisone (prednisone tablets, usp)
• Prograf (tacrolimus)
• Protopic (tacrolimus)
• Rituxan (rituximab)